Advances in targets in inflammatory breast cancer

Toshiaki Iwase; Xiaoping Wang; Lan Thi Hanh Phi; Nithya Sridhar; Naoto T Ueno; Jangsoon Lee

doi:10.1016/bs.ircmb.2023.10.005

Advances in targets in inflammatory breast cancer

Int Rev Cell Mol Biol. 2024:384:125-152. doi: 10.1016/bs.ircmb.2023.10.005. Epub 2024 Feb 5.

Authors

Toshiaki Iwase¹, Xiaoping Wang², Lan Thi Hanh Phi², Nithya Sridhar³, Naoto T Ueno⁴, Jangsoon Lee²

Affiliations

¹ Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; University of Hawaii Cancer Center, Honolulu, HI, United States. Electronic address: tiwase@cc.hawaii.edu.
² Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
³ Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
⁴ Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; University of Hawaii Cancer Center, Honolulu, HI, United States.

PMID: 38637096
DOI: 10.1016/bs.ircmb.2023.10.005

No abstract available

Keywords: AXL receptor tyrosine kinase; Enhancer of zeste homolog 2 protein; Epidermal growth factor receptor; Inflammatory breast neoplasm; Macrophages; X-linked inhibitor of apoptosis protein.

MeSH terms

Axl Receptor Tyrosine Kinase
Breast Neoplasms* / drug therapy
Cell Proliferation
Female
Humans
Inflammatory Breast Neoplasms* / therapy
Protein Kinase Inhibitors
Receptor Protein-Tyrosine Kinases

Substances

Receptor Protein-Tyrosine Kinases
Axl Receptor Tyrosine Kinase
Protein Kinase Inhibitors